Adiponectin Testing Market Share

North American Market Forecast   

The North American adiponectin testing market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market can be attributed majorly to the rising cases of cardiometabolic diseases and a growing population with obesity. Data released by the Centers for Disease Control and Prevention demonstrated the fact that approximately 659,000 people lose their lives due to heart diseases annually solely in the United States. Furthermore, up-surged manufacturing of testing laboratories in the region is anticipated to boost the growth of the market in the region. Also, the increasing number of people suffering from being overweight, the rising population with type 2 diabetes, and other metabolic syndromes are estimated to boost the market growth. The increasing adoption of a high-calorie diet by most people with no physical activity or work is estimated to propel market growth. People prefer ready-to-eat food as it does not require much cooking time as people are busy in their work life. Rising stress, anxiety, and tension also increase blood pressure leading to cardiovascular disorders thereby increasing the market growth.

APAC Market Statistics

Furthermore, the Asia Pacific region is anticipated to represent lucrative opportunities for the growth of the market over the forecast period. The growth of the market in the region is ascribed to rising investments in healthcare R&D activities and a growing geriatric population with cardio metabolism and chronic diseases. Such factors are estimated to boost the growth of the market in the region over the forecast period.